ING Groep NV lifted its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 8.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 62,116 shares of the company's stock after acquiring an additional 5,048 shares during the quarter. ING Groep NV's holdings in HCA Healthcare were worth $16,814,000 as of its most recent filing with the Securities and Exchange Commission.
- These are the Top 4 Stocks for Buybacks in 2024
Other institutional investors have also recently bought and sold shares of the company. Kinetic Partners Management LP acquired a new position in HCA Healthcare in the third quarter worth approximately $50,524,000. EP Wealth Advisors LLC lifted its stake in shares of HCA Healthcare by 501.8% in the 3rd quarter. EP Wealth Advisors LLC now owns 208,965 shares of the company's stock valued at $51,401,000 after purchasing an additional 174,240 shares during the last quarter. Retirement Systems of Alabama raised its holdings in HCA Healthcare by 350.0% during the fourth quarter. Retirement Systems of Alabama now owns 204,812 shares of the company's stock valued at $55,439,000 after buying an additional 159,303 shares in the last quarter. Canada Pension Plan Investment Board boosted its stake in shares of HCA Healthcare by 51.6% during the 3rd quarter. Canada Pension Plan Investment Board now owns 355,730 shares of the company's stock worth $87,502,000 after acquiring an additional 121,100 shares in the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp raised its stake in shares of HCA Healthcare by 83.4% in the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 254,408 shares of the company's stock valued at $62,579,000 after acquiring an additional 115,720 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.
Insider Buying and Selling at HCA Healthcare
In related news, EVP Michael S. Cuffe sold 6,311 shares of the firm's stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $316.88, for a total value of $1,999,829.68. Following the completion of the sale, the executive vice president now owns 29,624 shares of the company's stock, valued at $9,387,253.12. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 6,311 shares of the business's stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $316.88, for a total transaction of $1,999,829.68. Following the completion of the sale, the executive vice president now directly owns 29,624 shares of the company's stock, valued at approximately $9,387,253.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 1,600 shares of the business's stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the sale, the executive vice president now directly owns 34,124 shares of the company's stock, valued at $10,544,316. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,617 shares of company stock worth $4,321,986. 1.60% of the stock is currently owned by corporate insiders.
HCA Healthcare Price Performance
- Michael Burry’s New Stock Picks That You Might Want To Buy
HCA Healthcare stock traded up $0.15 during mid-day trading on Friday, hitting $322.86. 739,182 shares of the company were exchanged, compared to its average volume of 1,119,501. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $335.83. The company has a quick ratio of 1.02, a current ratio of 1.16 and a debt-to-equity ratio of 29.26. The business has a fifty day moving average of $319.96 and a 200 day moving average of $303.37. The company has a market capitalization of $84.56 billion, a PE ratio of 16.09, a price-to-earnings-growth ratio of 1.50 and a beta of 1.66.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, topping the consensus estimate of $5.01 by $0.35. The firm had revenue of $17.34 billion for the quarter, compared to analysts' expectations of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The company's quarterly revenue was up 11.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $4.93 earnings per share. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 20.79 earnings per share for the current year.
- Is Humana’s pain HCA Healthcare’s gain?
HCA Healthcare announced that its Board of Directors has authorized a share repurchase plan on Tuesday, January 30th that permits the company to repurchase $6.00 billion in outstanding shares. This repurchase authorization permits the company to purchase up to 7.4% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's board of directors believes its stock is undervalued.
HCA Healthcare Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be given a dividend of $0.66 per share. The ex-dividend date is Friday, June 14th. This represents a $2.64 annualized dividend and a yield of 0.82%. HCA Healthcare's dividend payout ratio (DPR) is 13.16%.
Analyst Ratings Changes
A number of analysts have recently weighed in on the stock. TD Cowen reduced their price objective on shares of HCA Healthcare from $371.00 to $360.00 and set a "buy" rating for the company in a research note on Tuesday, April 30th. Oppenheimer lifted their price objective on HCA Healthcare from $330.00 to $345.00 and gave the stock an "outperform" rating in a research note on Monday, April 29th. Deutsche Bank Aktiengesellschaft raised their target price on HCA Healthcare from $330.00 to $359.00 and gave the company a "buy" rating in a report on Friday, April 12th. Truist Financial raised their price objective on shares of HCA Healthcare from $320.00 to $345.00 and gave the stock a "buy" rating in a research note on Wednesday, January 31st. Finally, Barclays raised their price target on shares of HCA Healthcare from $356.00 to $367.00 and gave the stock an "overweight" rating in a research report on Monday, April 29th. Four research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $317.00.
Read Our Latest Analysis on HCA Healthcare
About HCA Healthcare
(Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Recommended Stories
- Five stocks we like better than HCA Healthcare
- What Does a Stock Split Mean?
- MarketBeat Week in Review – 5/13 - 5/17
- What is Insider Trading? What You Can Learn from Insider Trading
- Take-Two Interactive Software Offers 2nd Chance for Investors
- Investing in Travel Stocks Benefits
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
→ Warren Buffett's "mystery stock" (From Stansberry Research) (Ad)
Should you invest $1,000 in HCA Healthcare right now?
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
7 Stocks to Buy And Hold Forever
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
